Get the Stockscreener App
15.87
2.70%
-0.44
Caredx Inc stock is traded at $15.87, with a volume of 1.21M.
It is down -2.70% in the last 24 hours and up +9.22% over the past month.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
See More
Previous Close:
$16.31
Open:
$16.16
24h Volume:
1.21M
Relative Volume:
0.91
Market Cap:
$844.71M
Revenue:
$312.78M
Net Income/Loss:
$-143.56M
P/E Ratio:
-5.8996
EPS:
-2.69
Net Cash Flow:
$1.22M
1W Performance:
+5.73%
1M Performance:
+9.22%
6M Performance:
-1.61%
1Y Performance:
-30.33%
1-Day Range:
$15.80
$16.24
1-Week Range:
$14.72
$17.09
52-Week Range:
$10.96
$26.37
Caredx Inc Stock (CDNA) Company Profile
Name
Caredx Inc
Sector
Industry
Phone
415-287-2300
Address
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
15.87 | 838.87M | 312.78M | -143.56M | 1.22M | -2.69 |
|
TMO
Thermo Fisher Scientific Inc
|
580.13 | 220.92B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
221.20 | 154.97B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
701.48 | 56.98B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
146.89 | 42.96B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
223.55 | 37.62B | 15.90B | 1.28B | 2.21B | 7.2842 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-26-25 | Initiated | William Blair | Mkt Perform |
| Jan-15-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Aug-19-24 | Upgrade | BTIG Research | Neutral → Buy |
| May-13-24 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-09-23 | Upgrade | Stephens | Equal-Weight → Overweight |
| Aug-15-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-11-23 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-07-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Mar-03-23 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-03-23 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Jul-20-21 | Resumed | BTIG Research | Buy |
| Jun-03-21 | Initiated | Goldman | Buy |
| Feb-26-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-30-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-08-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-02-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-05-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-26-20 | Initiated | BTIG Research | Buy |
| Jun-19-20 | Reiterated | H.C. Wainwright | Buy |
| Oct-01-19 | Resumed | Craig Hallum | Buy |
| May-09-19 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Feb-15-19 | Initiated | Jefferies | Buy |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Sep-18-18 | Reiterated | H.C. Wainwright | Neutral |
| Nov-27-17 | Initiated | H.C. Wainwright | Buy |
| Jun-14-16 | Reiterated | Mizuho | Buy |
| Sep-29-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-25-15 | Initiated | Craig Hallum | Buy |
| Mar-18-15 | Reiterated | Mizuho | Buy |
View All
Caredx Inc Stock (CDNA) Latest News
Can CareDx Inc (1K9) stock expand revenue streamsMarket Sentiment Report & Daily Profit Focused Screening - newser.com
Is CareDx Inc stock trading near support levelsDollar Strength & Short-Term Trading Alerts - newser.com
Why CareDx Inc (1K9) stock remains stableWeekly Profit Analysis & Long-Term Safe Investment Plans - newser.com
What dividend safety score for CareDx Inc stockQuarterly Profit Review & Consistent Profit Trading Strategies - newser.com
Trend analysis for CareDx Inc this weekJuly 2025 Market Mood & Low Drawdown Investment Strategies - newser.com
We Believe CareDx's (NASDAQ:CDNA) Earnings Are A Poor Guide For Its Profitability - simplywall.st
What is the fair value estimate for CareDx Inc (1K9) stock in 2025Quarterly Trade Summary & Weekly Watchlist for Consistent Profits - newser.com
Detecting price anomalies in CareDx Inc with AIJuly 2025 Market Mood & Low Risk Investment Opportunities - newser.com
CareDx to Participate in Upcoming Investor ConferencesNovember 10, 2025 - BioSpace
Officer Novack Sells 2,688 ($41.7K) Of CareDx Inc [CDNA] - TradingView
[Form 4] CareDx, Inc. Insider Trading Activity - Stock Titan
Applying sector rotation models to CareDx IncWeekly Market Report & AI Powered Buy and Sell Recommendations - newser.com
CareDx (Nasdaq: CDNA) to join Stephens Nov 19 and Piper Sandler Dec 3 investor events - Stock Titan
Will CareDx Inc (1K9) stock keep high P E multiplesJuly 2025 Short Interest & Fast Entry and Exit Trade Plans - newser.com
CareDx Inc. Reports Strong Q3 Earnings Growth - MSN
CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches - MSN
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Joplin Globe
CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - BioSpace
Can you recover from losses in CareDx IncJuly 2025 Recap & Weekly Market Pulse Alerts - newser.com
CareDx, Inc. Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - MarketScreener
BTIG Maintains CareDx (CDNA) Buy Recommendation - MSN
CareDx, Inc (NASDAQ:CDNA) Q3 2025 Earnings Call Transcript - Insider Monkey
3 Analysts Have This To Say About CareDx - Benzinga
CareDx Reports Strong Q3 2025 Financial Results - MSN
CDNA: BTIG Raises Price Target to $25, Maintains Buy Rating | CD - GuruFocus
Caredx Inc Stock (CDNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
2.08%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):